Johnson & Johnson (JNJ:NYS) and Bristol-Myers Squibb (BMY:NYS) Downgraded

Stockcalc – Free Trial

Have a free look inside the StockCalc website at www.stockcalc.com/registration2.aspx

I have used the analysis tools on the website stockcalc.com to generate some of the content of this blog post. These tools and reports are available for free at www.stockcalc.com/toppicks.aspx.

Downgraded Stocks on NYSE, NASDAQ, AMEX, TSE, and TSX

Today we are looking at companies whose share price has been downgraded by at least one analyst in the last few days.

Why Do Companies Get Downgraded?

Companies can get downgraded for a number of reasons but primarily due to reduced future earnings potential due to loss of contracts, faultering product lines, increasing costs relative to revenue or financial risk.

In the list below you can see the number of analysts we have in the StockCalc database along with the number of buy-hold-sell on the company.

Today’s Data on NYSE, NASDAQ, AMEX, TSE, and TSX

Below we have today’s data for companies listed on all of the New York Stock Exchange, NASDAQ Stock Exchange, American Stock Exchange, Toronto Stock Exchange, and TSX Venture Exchange.

New York Stock Exchange
Symbol Name Buy Out Perform Hold Under Perform Sell No Opinion Mean Rating Prev Mean Rating Mean Label
JNJ Johnson & Johnson 4 0 1 1 0 0 4.1667 4.3333 Outperform
BMY Bristol-Myers Squibb Company 2 1 3 0 1 0 3.4286 3.5714 Hold
SLF Sun Life Financial Inc 4 0 7 0 0 0 3.7273 3.8182 Outperform
OKS ONEOK Partners LP 1 0 1 0 1 0 3.0000 3.3333 Hold
PVH PVH Corp 2 0 2 0 0 0 4.0000 4.2500 Outperform
NFG National Fuel Gas Co 1 0 2 0 0 0 3.6667 4.0000 Outperform
MMS Maximus Inc 0 0 3 0 0 0 3.0000 3.6667 Hold
Toronto Stock Exchange
Symbol Name Buy Out Perform Hold Under Perform Sell No Opinion Mean Rating Prev Mean Rating Mean Label
SLF Sun Life Financial Inc 4 0 7 0 0 0 3.7273 3.8182 Outperform
CEU Canadian Energy Services & Technology Corp 6 2 2 0 0 0 4.4000 4.4444 Outperform
AFN Ag Growth International Inc 0 2 1 0 0 0 3.6667 4.0000 Outperform
AUP Aurinia Pharmaceuticals Inc 3 1 0 0 0 0 4.7500 4.8000 Buy
PPY Painted Pony Petroleum Ltd 3 4 3 0 1 0 3.7273 3.8000 Outperform
IPCI IntelliPharmaCeutics International Inc 1 1 1 0 0 0 4.0000 4.6667 Outperform
TSX Venture Exchange
Symbol Name Buy Out Perform Hold Under Perform Sell No Opinion Mean Rating Prev Mean Rating Mean Label
ICG Integra Gold Corp 4 6 0 0 0 0 4.4000 4.4444 Outperform
NASDAQ
Symbol Name Buy Out Perform Hold Under Perform Sell No Opinion Mean Rating Prev Mean Rating Mean Label
AKRX Akorn Inc 2 0 2 0 0 0 4.0000 4.2500 Outperform
PFPT Proofpoint Inc 4 0 1 0 0 0 4.6000 4.6667 Buy
CUNB CU Bancorp 0 0 2 0 0 0 3.0000 4.0000 Hold
AUPH Aurinia Pharmaceuticals Inc 3 1 0 0 0 0 4.7500 4.8000 Buy
XCRA Xcerra Corp 0 0 1 0 0 0 3.0000 5.0000 Hold
IPCI IntelliPharmaCeutics International Inc 1 1 1 0 0 0 4.0000 4.6667 Outperform

Let’s look at a few companies…

Lets look at a couple of the companies on this list to get a better understanding of them.

JNJ:NYS Johnson & Johnson

http://www.jnj.com
Johnson & Johnson has 126400 employees and is headquartered in United States.
Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of products in the health care field within its Consumer, Pharmaceutical and Medical Devices segments.

BMY:NYS Bristol-Myers Squibb

http://www.bms.com
Bristol-Myers Squibb has 25000 employees and is headquartered in United States.
Bristol-Myers Squibb Co is a biopharmaceutical company. It discovers, develops, licenses, manufactures, markets, distributes and sells biopharmaceutical products.

Free Valuation

Run a valuation on any of the companies listed above at www.stockcalc.com/valureport.aspx or subscribe at our Stockcalc Facebook Page to receive this list each day Stockcalc Reports.

The content presented here is in part from the website stockcalc.com and is provided on an as is or as available basis with all faults and may not be current in all cases. You should not rely on any of the information as authoritative or as a substitute for the exercise of your own skill and judgment in making an investment decision.